Chemotherapy pp 581-583 | Cite as

Chemotherapeutic Management of Non-Hodgkin’s Lymphoma: Comparative Study of Various Combinations

  • Nazli Gad-el-Mawla
Part of the Chemotherapy book series (CT, volume 8)

Summary

74 patients with non-Hodgkin’s lymphoma attending the Medical Oncology Dept., Cancer Institute, Cairo University, received at random two regimens of combination chemotherapy. The group who received MOPP achieved 60%, while the group receiving CPP achieved 56% CR.

Although malignant lymphoma patients represent 7.8% of those attending the Cairo Cancer Institute annually, yet amongst those attending the Medical Oncology Dept.: Medical and Pediatric Units, it stands the first.

Non-Hodgkin’s lymphoma cases are more prevalent than Hodgkin’s cases. Thus, in the year 1973, amongst 281 cases of malignant lymphoma attending the Cairo Cancer Institute, 127 were of the Non-Hodgkin’s type, with the lymphocytic type predominating.

Chemotherapeutic management of Non-Hodgkin’s lymphoma still poses an international problem. For us, its management is of particular importance due to its prevalence together with the fact that we usually deal with advanced stages : III & IV. 75% of our cases belong to stage IV. Moreover, the diffuse type is more prevalent than the nodular type.

The present study evaluates the results of combination chemotherapy in patients with Non-Hodgkin’s lymphoma.

Keywords

Lymphoma Sedimentation Phoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bonadonna. G., De Lena. M., Lattuada, A.(1974). Br. J. Cancer, (in press).Google Scholar
  2. 2.
    Hoogstraten, B. (1969): Blood 33:370.Google Scholar
  3. 3.
    Lowenbraun, S., De Vita, V.T., Serpick, A.A.(1970). Cancer 25: 1018.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Nazli Gad-el-Mawla
    • 1
  1. 1.Cancer InstituteCairo UniversityCairoEgypt

Personalised recommendations